Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
233.1 USD | -1.54% | +6.16% | -9.72% |
03:36pm | US FDA panel to vote on data, risk profile of Lilly Alzheimer's drug | RE |
01:12pm | Wedbush Adjusts Price Target on Biogen to $215 From $219 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.72% | 34.47B | |
+0.99% | 91.72B | |
0.00% | 39.44B | |
+64.64% | 26.7B | |
-16.43% | 15.13B | |
-7.03% | 13.27B | |
-11.77% | 11.74B | |
-49.19% | 10.54B | |
+8.09% | 9.41B | |
+141.62% | 9.22B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Biogen : Canaccord Genuity Adjusts Biogen's Price Target to $423 From $359, Reiterates Buy Rating